Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

CYTODYN INC. (CYDY) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

CYTODYN INC. (CYDY), most recent 12 months reported: net loss $57.09M. Latest balance sheet on file: liquid cash $11.85M, total debt $27.2M, net cash -$15.35M. From SEC filings. Others in Pharmaceutical Preparations: Citius Oncology, Inc. · Citius Pharmaceuticals, Inc. · Curanex Pharmaceuticals Inc · Cadrenal Therapeutics, Inc. · CYPHERPUNK TECHNOLOGIES INC. · Decoy Therapeutics Inc. · DiaMedica Therapeutics Inc. · DAMORA THERAPEUTICS, INC.

Stock screener

Watchlist